Thrombopoietin Receptor Agonist [EPC]

15182 reported adverse events

Drugs of this class: ROMIPLOSTIM

These side effects are most commonly reported by patients taking drugs of the Thrombopoietin Receptor Agonist [EPC] class:

# Side effect Count
0 PLATELET COUNT DECREASED 1778
1 DRUG INEFFECTIVE 1768
2 OFF LABEL USE 1282
3 THROMBOCYTOPENIA 1048
4 DEATH 1016
5 PLATELET COUNT ABNORMAL 962
6 THERAPEUTIC RESPONSE DECREASED 942
7 HEADACHE 616
8 FATIGUE 478
9 PLATELET COUNT INCREASED 404
See all common reactions for Thrombopoietin Receptor Agonist [EPC]

Drugs of the Thrombopoietin Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE MARROW RETICULIN FIBROSIS 117 0.4535
1 BIOPSY BONE MARROW ABNORMAL 90 0.1982
2 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 89 0.1939
3 MUCOCUTANEOUS HAEMORRHAGE 28 0.1879
4 PLATELET COUNT ABNORMAL 962 0.1590
5 SPLENECTOMY 138 0.1188
6 EVANS SYNDROME 51 0.1034
7 THROMBOCYTOSIS 341 0.0930
8 IDIOPATHIC THROMBOCYTOPENIC PURPURA 85 0.0538
9 MYELOFIBROSIS 158 0.0522
See all enriched reactions for Thrombopoietin Receptor Agonist [EPC]